OPM(688293.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
OPM
688293.SH
Shanghai OPM Biosciences Co., Ltd. provides cell culture media and CDMO services in China and internationally. The company offers cell culture media and feed supplements, such as OPM's CHO-Platform, OPM-293 Platform, and VegaCHO media and feeds, as well as customized cell culture media development services. It also provides end-to-end biologics CDMO services, such as antibody discovery, stable cell line development, cell banking, upstream process development, downstream process development, formulation development, and quality control and product characterization of biologics.
1.470 T
688293.SHMarket value -Rank by Market Cap -/-

Financial Score

21/05/2026 Update
B
BiotechnologyIndustry
Industry Ranking16/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE2.73%C
    • Profit Margin14.61%B
    • Gross Margin43.79%B
  • Growth ScoreA
    • Revenue YoY50.52%A
    • Net Profit YoY310.49%A
    • Total Assets YoY87.27%A
    • Net Assets YoY29.94%A
  • Cash ScoreB
    • Cash Flow Margin83.63%C
    • OCF YoY50.52%A
  • Operating ScoreE
    • Turnover0.14E
  • Debt ScoreB
    • Gearing Ratio36.53%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    OPM's subsidiary passes EU QP audit

    Zhitong·
    SH
    688293
    -3.31%
    Zhitong·
    SH
    688293
    -3.31%

    CRO concept stocks fluctuate and rise, Jiuzhou Pharma hits the limit up

    Zhitong·
    SZ
    000739
    +0.95%
    SH
    603456
    -0.38%
    SH
    603127
    +10.01%
    Zhitong·
    SZ
    000739
    +0.95%
    SH
    603456
    -0.38%
    SH
    603127
    +10.01%

    Zhitong A-share lock-up release overview | September 2

    Zhitong·
    SZ
    002340
    -3.81%
    SZ
    301296
    -3.67%
    SZ
    002439
    -5.22%
    Zhitong·
    SZ
    002340
    -3.81%
    SZ
    301296
    -3.67%
    SZ
    002439
    -5.22%

    OPM: Expected net profit of approximately 37 million yuan in the first half of the year, a year-on-year increase of 53.28%

    Zhitong·
    SH
    688293
    -3.31%
    Zhitong·
    SH
    688293
    -3.31%

    The biopharmaceutical sector continues to adjust, with *ST Four Rings hitting the daily limit down, Rongchang Bio falling over 18%, and Mabwell, SDKX, Science Sun Pharm, OPM, Aidea Pharma, and others following suit

    Zhitong·
    SH
    688293
    -3.31%
    SH
    688488
    -1.25%
    SZ
    300485
    -5.49%
    Zhitong·
    SH
    688293
    -3.31%
    SH
    688488
    -1.25%
    SZ
    300485
    -5.49%
    © 2026 Longbridge｜Disclaimer